Geode Capital Management, LLC Protalix Bio Therapeutics, Inc. Transaction History
Geode Capital Management, LLC
- $1.07 Trillion
- Q1 2024
A detailed history of Geode Capital Management, LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 754,110 shares of PLX stock, worth $844,603. This represents 0.0% of its overall portfolio holdings.
Number of Shares
754,110
Previous 724,575
4.08%
Holding current value
$844,603
Previous $1.29 Million
26.3%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PLX
# of Institutions
66Shares Held
9.27MCall Options Held
40.6KPut Options Held
10.1K-
Black Rock Inc. New York, NY3.31MShares$3.71 Million0.0% of portfolio
-
State Street Corp Boston, MA827KShares$925,7700.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny825KShares$923,6640.0% of portfolio
-
Gsa Capital Partners LLP London, X0494KShares$552,7990.05% of portfolio
-
Northern Trust Corp Chicago, IL458KShares$513,1220.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $55.7M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...